Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
INP
iPath ETNs Linked to the MSCI India Total Return Index
INP
|
+$1.36B |
| 2 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$236M |
| 3 |
Apple
AAPL
|
+$223M |
| 4 |
State Street Utilities Select Sector SPDR ETF
XLU
|
+$222M |
| 5 |
Southern Company
SO
|
+$182M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
FON
SPRINT CORP FON COM
FON
|
+$724M |
| 2 |
Pfizer
PFE
|
+$469M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$409M |
| 4 |
iShares US Real Estate ETF
IYR
|
+$407M |
| 5 |
Zoetis
ZTS
|
+$215M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 4.63% |
| 2 | Healthcare | 4.25% |
| 3 | Technology | 4.18% |
| 4 | Energy | 3.42% |
| 5 | Communication Services | 3.3% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
5026
PUT
Comstock Resources
CRK
$3.88B
| $183K | ﹤0.01% |
2,440
-4,900
| -67% | -$392K |
|
5027
PUT
State Street SPDR S&P Bank ETF
KBE
$1.66B
| $183K | ﹤0.01% |
6,100
+4,000
| +190% | +$122K |
|
|
WBC
5028
DELISTED
WABCO HOLDINGS INC.
WBC
| $183K | ﹤0.01% |
2,173
-7,153
| -77% | -$573K |
|
|
EMBJ
5029
CALL
Embraer S.A. ADS
EMBJ
$12.8B
| $182K | ﹤0.01% |
5,700
+3,400
| +148% | +$118K |
|
5030
State Street SPDR Portfolio Short Term Corporate Bond ETF
SPSB
$10.6B
| $182K | ﹤0.01% |
6,050
-168,532
| -97% | -$5.16M |
|
|
ARRY
5031
DELISTED
Array Biopharma Inc
ARRY
| $182K | ﹤0.01% |
30,210
+9,676
| +47% | +$57.5K |
|
|
ANSS
5032
PUT
DELISTED
Ansys
ANSS
| $181K | ﹤0.01% |
2,100
-2,600
| -55% | -$217K |
|
|
DX
5033
Dynex Capital
DX
$3.18B
| $181K | ﹤0.01% |
7,556
-217
| -3% | -$5.8K |
|
5034
CALL
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
$32.9B
| $181K | ﹤0.01% |
1,600
-158,400
| -99% | -$17.9M |
|
|
MVT
5035
DELISTED
BlackRock MuniVest Fund II
MVT
| $181K | ﹤0.01% |
12,904
+2,534
| +24% | +$36.5K |
|
5036
CALL
Ameren
AEE
$30B
| $180K | ﹤0.01% |
5,300
+2,500
| +89% | +$86.6K |
|
5037
Immersion
IMMR
$246M
| $180K | ﹤0.01% |
13,884
+6,957
| +100% | +$95.4K |
|
5038
CALL
ManpowerGroup
MAN
$2.57B
| $180K | ﹤0.01% |
2,500
-200
| -7% | -$13.4K |
|
5039
PUT
Madison Square Garden
MSGS
$9.43B
| $180K | ﹤0.01% |
4,346
+561
| +15% | +$23.6K |
|
|
XIN
5040
DELISTED
Xinyuan Real Estate
XIN
| $180K | ﹤0.01% |
3,004
+1,073
| +56% | +$57.9K |
|
|
MTGE
5041
DELISTED
MTGE Investment Corp. Common Stock
MTGE
| $180K | ﹤0.01% |
9,463
+7,576
| +401% | +$147K |
|
5042
iShares MSCI Peru and Global Exposure ETF
EPU
$559M
| $179K | ﹤0.01% |
5,598
-2,000
| -26% | -$67K |
|
|
PCH
5043
DELISTED
PotlatchDeltic
PCH
| $179K | ﹤0.01% |
4,586
-11,400
| -71% | -$468K |
|
5044
Wipro
WIT
$19.7B
| $179K | ﹤0.01% |
95,147
-224,176
| -70% | -$377K |
|
|
PGNX
5045
DELISTED
Progenics Pharmaceuticals Inc
PGNX
| $179K | ﹤0.01% |
35,745
-24,574
| -41% | -$133K |
|
|
CBR
5046
DELISTED
CIBER Inc.
CBR
| $179K | ﹤0.01% |
59,888
-34,175
| -36% | -$123K |
|
5047
Vicor
VICR
$10.1B
| $178K | ﹤0.01% |
22,341
-5,474
| -20% | -$43.7K |
|
5048
WisdomTree
WT
$3.25B
| $178K | ﹤0.01% |
16,224
-44,123
| -73% | -$533K |
|
|
ICPT
5049
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
| $178K | ﹤0.01% |
2,588
+2,260
| +689% | +$112K |
|
5050
8x8 Inc
EGHT
$328M
| $177K | ﹤0.01% |
17,702
+13,156
| +289% | +$123K |
|
Similar funds
Barclays's Q3 2013 Portfolio in Review
As of Q3 2013, Barclays held 8,017 positions worth $83.8B, up 4.2% from $80.4B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Barclays's Q3 2013 filing shows 302 new, 3,328 increased, 3,470 reduced and 580 closed positions. Its largest new stake was Twenty-First Century Fox, Inc. Class A: 2,167,568 shares worth $71.5M. The largest sale was SPRINT CORP FON COM, an estimated $724M.
By sector, the portfolio is most concentrated in Financials at 4.6% of assets, up from 4.5% a quarter earlier, followed by Healthcare and Technology.
- Barclays's largest Q3 2013 buy was Twenty-First Century Fox, Inc. Class A: 2,167,568 shares worth $71.5M.
- Barclays added most to iPath ETNs Linked to the MSCI India Total Return Index in Q3 2013, an estimated $1.36B increase.
- Barclays's biggest Q3 2013 reduction was Pfizer, cutting an estimated $469M.
- Barclays fully exited SPRINT CORP FON COM in Q3 2013, selling an estimated $724M.
- Barclays's ten largest holdings make up 26% of its $83.8B portfolio in Q3 2013.
- Barclays opened 302 new positions and closed 580 in Q3 2013.
- Barclays's portfolio value rose 4.2% quarter-over-quarter to $83.8B.
Based on Barclays's 13F filing for Q3 2013, filed 14 Nov 2013.